eli lilly foundayo - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

eli lilly foundayo

Eli Lilly Foundayo GLP-1 weight-loss pill concept in a modern laboratory setting.

Pharma & Healthcare·Stocks·USA

Eli Lilly Foundayo Soars +4.6% as GLP-1 Pill Bets Grow

By Maik Kemper • Apr 1, 2026

Eli Lilly Foundayo GLP-1 weight-loss pill concept in a modern laboratory setting.

Pharma & Healthcare·Stocks·USA

Eli Lilly Foundayo Soars +4.6% as GLP-1 Pill Bets Grow

By Maik Kemper • Apr 1, 2026

Can Eli Lilly Foundayo and the Centessa deal push Lilly’s GLP-1 dominance into an even more powerful multi-drug growth story? Maik Kemper Editor in Chief…